WHO ICTRP trial
A PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CLENBUTEROL IN…
EUCTR2017-005103-27-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2017-005103-27-IT |
|---|---|
| Public title | A PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CLENBUTEROL IN PATIENTS WITH SPINAL AND BULBAR MUSCULAR ATROPHY (SBMA) |
| Scientific title | A PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CLENBUTEROL IN PATIENTS WITH SPINAL AND BULBAR MUSCULAR ATROPHY (SBMA) - BETA SBMA |
| Primary sponsor | AZIENDA OSPEDALIERA DI PADOVA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Italy |
| Conditions | Motor neuron disease characterized by atrophy and muscle weakness in the spinal and bulbar region MedDRA version: 20.1 Level: PT Classification code 10068597 Term: Bulbospinal muscular atrophy congenital System Organ Class: 10010331… |
| Interventions | Trade Name: MONORES 20 mcg 30 compresse Product Name: MONORES 20 mcg 30 compresse Product Code: [024217034] Pharmaceutical Form: Tablet INN or Proposed INN: CLENBUTEROLO Current Sponsor code: nessuno Concentration unit: µg microgram(s)… |
| Registration date | Oct 23, 2020 |
| Target size | 90 |
| Secondary IDs | BETASBMA |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: